綜合分析報告: NVO - Novo Nordisk A/S

執行摘要

當前價格

$52.96

市值

$236.41B

本益比

13.649484

評級

BUY

分數: 61.6/100

投資論點

核心論點 / Core Thesis:

Analysis in progress...

優勢 / Strengths

資訊待補充 / Information pending

風險 / Risks

資訊待補充 / Information pending

技術分析

技術分數 / Technical Score: 37/100

Below key MAs (weakness) | RSI oversold (potential bounce) | MACD bearish | Below average volume | Room to resistance

📊 技術分析圖表 / Technical Analysis Charts

整體趨勢 / Overall Trend

Strong Bearish

動能 / Momentum

Neutral

RSI (14)

21.8 (Oversold)

日線圖 (1年趨勢) / Daily Chart (1-Year Trend)

1小時圖 (1個月趨勢) / 1-Hour Chart (1-Month Trend)

✅ 買入信號 / Buy Signals:

RSI 超賣 (< 30)

技術指標 / Technical Indicators

指標 / Indicator	數值 / Value
50日均線 / 50-Day MA	$56.47
200日均線 / 200-Day MA	$67.99
RSI (14)	21.819727913018554
Beta	0.331

基本面分析

基本面分數 / Fundamental Score: 78/100

Exceptional growth (>20%) | Excellent profitability | Weak financial position | Low P/E (<15)

指標 / Metric	數值 / Value
營收成長 / Revenue Growth	12.90%
盈餘成長 / Earnings Growth	32.70%
ROE	79.17%
負債股本比 / Debt-to-Equity	59.065

估值分析

詳細估值分析由分析引擎生成 / Detailed valuation analysis generated by analysis engine

投資建議

BUY

{'action': 'STRONG BUY', 'conviction': 'High', 'rating': 5, 'target_price': 69.25, 'upside_potential': 30.8, 'position_size': '4-5% of portfolio', 'entry_strategy': 'Scale in: 2% at $52-53, +2% at $50-51, +1% post-catalyst', 'stop_loss': 45.0, 'time_horizon': '12-18 months'}

信心度 / Confidence: Medium

風險評估

風險評估由分析引擎生成 / Risk assessment generated by analysis engine

執行計畫

執行計畫由分析引擎生成 / Implementation plan generated by analysis engine